MARKET

LLY

LLY

Lilly Eli & Co
NYSE
878.31
+7.94
+0.91%
After Hours: 875.09 -3.22 -0.37% 19:59 02/07 EST
OPEN
876.53
PREV CLOSE
870.37
HIGH
889.36
LOW
869.62
VOLUME
4.43M
TURNOVER
1.97B
52 WEEK HIGH
970.92
52 WEEK LOW
678.10
MARKET CAP
833.79B
P/E (TTM)
74.98
1D
5D
1M
3M
1Y
5Y
1D
2 Growth Stocks to Buy Hand Over Fist in February
The Motley Fool · 4h ago
Guru Fundamental Report for LLY - Martin Zweig
NASDAQ · 4h ago
18 out of 21 healthcare companies beat profit estimates this week- Earnings scorecard
Seeking Alpha · 21h ago
Notable healthcare headlines for the week: Eli Lilly, Merck and Becton, Dickinson in focus
Seeking Alpha · 23h ago
Is Novo Nordisk Stock a Buy Now?
The Motley Fool · 1d ago
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
The Motley Fool · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of February 9
Seeking Alpha · 1d ago
Major Eli Lilly Shareholder Sells Massive Stock Holding
TipRanks · 1d ago
More
About LLY
Eli Lilly and Company is a medicine company. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz. Its neuroscience products include Cymbalta and Emgality. Its other products and therapies include Cialis and Forteo. It manufactures and distributes its products through facilities in the United States (U.S.), including Puerto Rico, and in Europe and Asia. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing, as well as clinical and pre-clinical radioligand therapies. It is also developing oral small molecule inhibitor of α4β7 integrin (known as MORF-057) for inflammatory bowel disease (IBD).

Webull offers Eli Lilly And Co stock information, including NYSE: LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.